Ketoconazole Related Published Studies
Well-designed clinical trials related to Ketoconazole (Ketoconazole Topical)
Multicenter, double-blind, parallel group study investigating the non-inferiority
of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2%
ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]
Multicenter, double-blind, parallel group study investigating the non-inferiority
of efficacy and safety of a 2% miconazole nitrate shampoo in comparison with a 2%
ketoconazole shampoo in the treatment of seborrhoeic dermatitis of the scalp. [2014]
Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0.05% combined with ketoconazole shampoo 2%: a randomized, controlled study. [2011.07]
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin or ciclosporin A. [2011.04]
Pharmacokinetics of oral neratinib during co-administration of ketoconazole in healthy subjects. [2011.04]
[Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis]. [2011.02]
Synergistic effects of tetrandrine on the antifungal activity of topical
ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011]
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in orabase in treatment of Candida-infected denture stomatitis. [2010.03.01]
Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. [2010.03]
Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6). [2010.01]
Effects of ketoconazole and carbamazepine on lapatinib pharmacokinetics in healthy subjects. [2009.04]
Effect of different durations of ketoconazole dosing on the single-dose pharmacokinetics of midazolam: shortening the paradigm. [2009.04]
An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis. [2009]
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction study. [2009]
Presystemic elimination of budesonide in man when administered locally at different levels in the gut, with and without local inhibition by ketoconazole. [2008.11.15]
Comparative efficacy and tolerability of Ketomousse (ketoconazole foam 1%) and ketoconazole cream 2% in the treatment of pityriasis versicolor: results of a prospective, multicentre, randomised study. [2008.11]
Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers. [2008.08]
Effects of ketoconazole and quinidine on pharmacokinetics of pactimibe and its plasma metabolite, R-125528, in humans. [2008.08]
Oral ketoconazole for prevention of postoperative penile erection: a placebo controlled, randomized, double-blind trial. [2008.05]
Effect of ketoconazole on the pharmacokinetics of maribavir in healthy adults. [2008.05]
Oral Ketoconazole for Prevention of Postoperative Penile Erection: A Placebo Controlled, Randomized, Double-Blind Trial. [2008.03.17]
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions. [2007.10]
The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during coadministration with ketoconazole. [2007.07]
The prokinetic cinitapride has no clinically relevant pharmacokinetic interaction and effect on QT during co-administration with ketoconazole. [2007.04.16]
Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study. [2007.04.01]
Effects of three cytochrome P450 inhibitors, ketoconazole, fluconazole, and paroxetine, on the pharmacokinetics of lasofoxifene. [2007.01]
Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. [2007]
Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole. [2007]
Effectiveness and tolerability of a standardized extract from Ageratina pichinchensis on patients with tinea pedis: an explorative pilot study controlled with ketoconazole. [2006.11]
Pharmacokinetic interaction between ketoconazole and SPP301 in healthy volunteers. [2006.07]
Efficacy and safety of a new once-daily topical ketoconazole 2% gel in the treatment of seborrheic dermatitis: a phase III trial. [2006.07]
Influence of high-dose ketoconazole on the pharmacokinetics of docetaxel. [2006.07]
Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. [2006.01]
Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study. [2006]
Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide. [2005.11]
The role of ketoconazole in the prevention of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during assisted reproductive technology cycles. [2005.10]
Comparison of the clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs--a pilot study. [2005.06]
Ketoconazole increases plasma concentrations of antimalarial mefloquine in healthy human volunteers. [2005.06]
Studies to investigate the pharmacokinetic interactions between ranolazine and ketoconazole, diltiazem, or simvastatin during combined administration in healthy subjects. [2005.04]
Effect of ketoconazole on the pharmacokinetics and safety of telithromycin and clarithromycin in older subjects with renal impairment. [2005.03]
Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences. [2005.03]
Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects. [2005.03]
A randomized, phase II trial of ketoconazole plus alendronate versus ketoconazole alone in patients with androgen independent prostate cancer and bone metastases. [2005.03]
Efficacy of a new antidandruff thermophobic foam: a randomized, controlled, investigator-blinded trial vs. ketoconazole 2% scalp fluid. [2005.01]
Well-designed clinical trials possibly related to Ketoconazole (Ketoconazole Topical)
Gender determines ACTH recovery from hypercortisolemia in healthy older humans. [2013]
Effects of CYP3A4 inhibition and induction on the pharmacokinetics and pharmacodynamics of tolvaptan a non-peptide AVP antagonist in healthy subjects. [2011.10.11]
Concurrent assessment of hepatic and intestinal cytochrome P450 3A activities using deuterated alfentanil. [2011.04]
Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone. [2011.01]
In vitro-in vivo correlation and translation to the clinical outcome for CJ-13,610, a novel inhibitor of 5-lipoxygenase. [2010.07]
Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. [2010.06]
Bioequivalence study of two formulations of 100 mg capsule of itraconazole. Quantification by tandem mass spectrometry. [2010]
Inhibition of oral midazolam clearance by boosting doses of ritonavir, and by 4,4-dimethyl-benziso-(2H)-selenazine (ALT-2074), an experimental catalytic mimic of glutathione oxidase. [2009.12]
Randomised controlled trial of the treatment of pastern dermatitis with a formulation containing kunzea oil. [2009.05.16]
Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection. [2009.04]
Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers. [2009.02]
A study to evaluate the efficacy and safety of oral fluconazole in the treatment of tinea versicolor. [2009.01]
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancer. [2008.12.20]
Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus. [2008.06]
The effects of CYP3A4 inhibition on erlotinib pharmacokinetics: computer-based simulation (SimCYP) predicts in vivo metabolic inhibition. [2008.01]
Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens. [2007.11.07]
Combination of surgical avulsion and topical therapy for single nail onychomycosis: a randomized controlled trial. [2007.08]
Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. [2007.05]
Preoperative immunosuppressive therapy and surgery as a treatment for anal furunculosis. [2006.12]
Retinoic acid as a novel medical therapy for Cushing's disease in dogs. [2006.09]
Intervention at the level of the neuroendocrine-immune axis and postoperative pneumonia rate in long-term alcoholics. [2006.08.15]
The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone. [2006.08]
Predictive power of an in vitro system to assess drug interactions of an antimuscarinic medication: a comparison of in vitro and in vivo drug-drug interaction studies of trospium chloride with digoxin. [2006.07]
Man versus machine: is there an optimal method for QT measurements in thorough QT studies? [2006.06]
Drugs for treating paracoccidioidomycosis. [2006.04.19]
Comparison of midazolam and simvastatin as cytochrome P450 3A probes. [2006.04]
A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos. [2005.12]
[Comparison of efficacy of combination of ketokonazol 400 mg + clindamycin 100 mg with ketokonazol 800 mg + clindamycin 100 mg in the treatment of vaginitis due to Candida and bacterial vaginosis] [2005.06]
Age and testosterone feedback jointly control the dose-dependent actions of gonadotropin-releasing hormone in healthy men. [2005.01]
Other research related to Ketoconazole (Ketoconazole Topical)
Combination therapy for Cushing's disease: effectiveness of two schedules of
treatment: should we start with cabergoline or ketoconazole? [2014]
Androgen synthesis in the gonadotropin-suppressed human testes can be markedly
suppressed by ketoconazole. [2013]
Effect of the CYP3A inhibitor ketoconazole on the PXR-mediated induction of CYP3A
activity. [2013]
Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic
castration-resistant prostate cancer: implications for prior therapy in clinical
trials. [2013]
Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers. [2012]
Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy subjects. [2011.12]
EFFECTS OF KETOCONAZOLE AND VALPROIC ACID ON THE PHARMACOKINETICS OF THE NEXT-GENERATION NNRTI LERSIVIRINE (UK-453,061) IN HEALTHY ADULT SUBJECTS. [2011.11.01]
A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients. [2011.09]
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor. [2011.09]
Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study. [2011.08.26]
Improved treatment of visceral leishmaniasis (kala-azar) by using combination of ketoconazole, miltefosine with an immunomodulator-Picroliv. [2011.08]
Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin. [2011.08]
Synergistic effects of tetrandrine on the antifungal activity of topical ketoconazole cream in the treatment of dermatophytoses: a clinical trial. [2011.07]
Low dose of ketoconazole in patients with prostate adenocarcinoma resistant to pharmacological castration. [2011.07]
Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers. [2011.04.26]
The effect of increased lipoprotein levels on the pharmacokinetics of ketoconazole enantiomers in the rat. [2011.02]
Physicochemical characterization and dissolution study of solid dispersions of ketoconazole with nicotinamide. [2011]
Pharmacokinetic interactions between alitretinoin and ketoconazole or simvastatin
or ciclosporin A. [2011]
Pharmacokinetics of oral neratinib during co-administration of ketoconazole in
healthy subjects. [2011]
Effect of ketoconazole on the pharmacokinetics of oral bosutinib in healthy
subjects. [2011]
Childhood acute generalized exanthematous pustulosis induced by oral ketoconazole. [2010.12]
Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers. [2010.08.26]
Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in mice. [2010.08]
Comparative evaluation of ketoconazole tablet and topical ketoconazole 2% in
orabase in treatment of Candida-infected denture stomatitis. [2010]
Intralesional sodium stibogluconate alone or its combination with either
intramuscular sodium stibogluconate or oral ketoconazole in the treatment of
localized cutaneous leishmaniasis: a comparative study. [2010]
Ketoconazole and prednisone to prevent recurrent ischemic priapism. [2009.10]
Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study. [2009.09.10]
Synergistic Anti-candidal Activity of Tetrandrine on Ketoconazole: an Experimental Study. [2009.07.30]
|